Reflecting its continued focus on helping healthcare organizations reduce costs through technological innovation, MedAssets (NASDAQ: MDAS) recently held its 11 th annual Technology & Innovation Forum. Approximately 70 suppliers of high-quality medical products and services showcased the newest healthcare and clinical technologies to more than 400 MedAssets provider clients who, in turn, offered valuable, real-world feedback on the supplier offerings.
During the day-long event, healthcare provider attendees—all of whom are key decision-makers for leading healthcare organizations—were introduced to a variety of innovative solutions designed to enhance care delivery, improve clinical performance, as well as contain costs.
The Technology & Innovation Forum was held in Dallas, Texas, in conjunction with the MedAssets Business and Technology Forum, a broader event designed to bring together suppliers and healthcare providers for professional networking, education and facilitation of new product development.
Commitment to InnovationIn a survey conducted at the event, the majority of attendees reported that the Technology & Innovation Forum directly benefits their facilities by providing access to new products and services. “MedAssets Technology & Innovation Forum was a key event for Ochsner Health System,” said Grant Walker, vice president, Supply Chain, Ochsner Health System. “Not only were we able to glimpse the future of healthcare innovation, but we also had the opportunity to actively engage suppliers and influence product development.” Participants were invited to exhibit at the forum based on several criteria, including degree of technological advancement of the product or service offering, as well as the product or service’s ability to reduce supply chain costs and/or improve care delivery. As part of MedAssets client-led sourcing structure, suppliers receiving a high ranking from event attendees and meeting MedAssets eligibility guidelines will continue through the sourcing process for consideration to be added to the MedAssets contract portfolio, which is comprised of more than 1,800 companies.